vs
Regency Centers（REG）与Revvity（RVTY）财务数据对比。点击上方公司名可切换其他公司
Revvity的季度营收约是Regency Centers的1.9倍（$772.1M vs $404.2M），Regency Centers净利率更高（50.1% vs 12.7%，领先37.4%），Regency Centers同比增速更快（8.5% vs 5.9%），过去两年Revvity的营收复合增速更高（9.0% vs 5.4%）
Regency Centers是总部位于美国佛罗里达州杰克逊维尔的房地产投资信托基金，也是以超市为核心租户的大型购物中心运营商之一。截至2020年10月21日，公司共持有415处物业，总建筑面积达5600万平方英尺，知名资产包括Serramonte Center及Village District 30%的股权。
Revvity是一家美国生命科学与诊断领域企业，主要服务制药、生物技术行业客户，重点围绕细胞治疗、基因治疗等前沿技术领域提供相关产品与解决方案，其前身为业务布局多元的老牌企业珀金埃尔默。
REG vs RVTY — 直观对比
营收规模更大
RVTY
是对方的1.9倍
$404.2M
营收增速更快
REG
高出2.6%
5.9%
净利率更高
REG
高出37.4%
12.7%
两年增速更快
RVTY
近两年复合增速
5.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $404.2M | $772.1M |
| 净利润 | $202.5M | $98.4M |
| 毛利率 | — | — |
| 营业利润率 | 71.0% | 14.5% |
| 净利率 | 50.1% | 12.7% |
| 营收同比 | 8.5% | 5.9% |
| 净利润同比 | 134.1% | 3.9% |
| 每股收益（稀释后） | — | $0.86 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收REGRVTY
| Q4 25 | $404.2M | $772.1M | ||
| Q3 25 | $387.6M | $698.9M | ||
| Q2 25 | $380.8M | $720.3M | ||
| Q1 25 | $380.9M | $664.8M | ||
| Q4 24 | $372.5M | $729.4M | ||
| Q3 24 | $360.3M | $684.0M | ||
| Q2 24 | $357.3M | $691.7M | ||
| Q1 24 | $363.9M | $649.9M |
净利润REGRVTY
| Q4 25 | $202.5M | $98.4M | ||
| Q3 25 | $109.4M | $46.7M | ||
| Q2 25 | $106.0M | $53.9M | ||
| Q1 25 | $109.6M | $42.2M | ||
| Q4 24 | $86.5M | $94.6M | ||
| Q3 24 | $101.5M | $94.4M | ||
| Q2 24 | $102.7M | $55.4M | ||
| Q1 24 | $109.8M | $26.0M |
毛利率REGRVTY
| Q4 25 | — | — | ||
| Q3 25 | — | 53.6% | ||
| Q2 25 | — | 54.5% | ||
| Q1 25 | — | 56.5% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 56.3% | ||
| Q2 24 | — | 55.7% | ||
| Q1 24 | — | 54.6% |
营业利润率REGRVTY
| Q4 25 | 71.0% | 14.5% | ||
| Q3 25 | 72.7% | 11.7% | ||
| Q2 25 | 73.8% | 12.6% | ||
| Q1 25 | 71.8% | 10.9% | ||
| Q4 24 | 71.1% | 16.3% | ||
| Q3 24 | 72.5% | 14.3% | ||
| Q2 24 | 72.3% | 12.4% | ||
| Q1 24 | 72.3% | 6.8% |
净利率REGRVTY
| Q4 25 | 50.1% | 12.7% | ||
| Q3 25 | 28.2% | 6.7% | ||
| Q2 25 | 27.8% | 7.5% | ||
| Q1 25 | 28.8% | 6.4% | ||
| Q4 24 | 23.2% | 13.0% | ||
| Q3 24 | 28.2% | 13.8% | ||
| Q2 24 | 28.7% | 8.0% | ||
| Q1 24 | 30.2% | 4.0% |
每股收益（稀释后）REGRVTY
| Q4 25 | — | $0.86 | ||
| Q3 25 | — | $0.40 | ||
| Q2 25 | — | $0.46 | ||
| Q1 25 | — | $0.35 | ||
| Q4 24 | — | $0.77 | ||
| Q3 24 | — | $0.77 | ||
| Q2 24 | — | $0.45 | ||
| Q1 24 | — | $0.21 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $919.9M |
| 总债务越低越好 | $4.7B | — |
| 股东权益账面价值 | $6.9B | $7.3B |
| 总资产 | $13.0B | $12.2B |
| 负债/权益比越低杠杆越低 | 0.69× | — |
8季度趋势，按日历期对齐
现金及短期投资REGRVTY
| Q4 25 | — | $919.9M | ||
| Q3 25 | — | $931.4M | ||
| Q2 25 | — | $991.8M | ||
| Q1 25 | — | $1.1B | ||
| Q4 24 | — | $1.2B | ||
| Q3 24 | — | $1.2B | ||
| Q2 24 | — | $2.0B | ||
| Q1 24 | — | $1.7B |
总债务REGRVTY
| Q4 25 | $4.7B | — | ||
| Q3 25 | $4.9B | — | ||
| Q2 25 | $4.8B | — | ||
| Q1 25 | $4.6B | — | ||
| Q4 24 | $4.4B | — | ||
| Q3 24 | $4.4B | — | ||
| Q2 24 | $4.4B | — | ||
| Q1 24 | $4.4B | — |
股东权益REGRVTY
| Q4 25 | $6.9B | $7.3B | ||
| Q3 25 | $6.8B | $7.4B | ||
| Q2 25 | $6.7B | $7.6B | ||
| Q1 25 | $6.7B | $7.6B | ||
| Q4 24 | $6.7B | $7.7B | ||
| Q3 24 | $6.8B | $7.9B | ||
| Q2 24 | $6.8B | $7.9B | ||
| Q1 24 | $7.0B | $7.8B |
总资产REGRVTY
| Q4 25 | $13.0B | $12.2B | ||
| Q3 25 | $13.1B | $12.1B | ||
| Q2 25 | $12.7B | $12.4B | ||
| Q1 25 | $12.6B | $12.4B | ||
| Q4 24 | $12.4B | $12.4B | ||
| Q3 24 | $12.4B | $12.8B | ||
| Q2 24 | $12.4B | $13.4B | ||
| Q1 24 | $12.7B | $13.4B |
负债/权益比REGRVTY
| Q4 25 | 0.69× | — | ||
| Q3 25 | 0.72× | — | ||
| Q2 25 | 0.72× | — | ||
| Q1 25 | 0.69× | — | ||
| Q4 24 | 0.66× | — | ||
| Q3 24 | 0.65× | — | ||
| Q2 24 | 0.64× | — | ||
| Q1 24 | 0.63× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $203.9M | $182.0M |
| 自由现金流经营现金流 - 资本支出 | — | $161.8M |
| 自由现金流率自由现金流/营收 | — | 21.0% |
| 资本支出强度资本支出/营收 | — | 2.6% |
| 现金转化率经营现金流/净利润 | 1.01× | 1.85× |
| 过去12个月自由现金流最近4个季度 | — | $509.4M |
8季度趋势，按日历期对齐
经营现金流REGRVTY
| Q4 25 | $203.9M | $182.0M | ||
| Q3 25 | $218.7M | $138.5M | ||
| Q2 25 | $244.0M | $134.3M | ||
| Q1 25 | $161.0M | $128.2M | ||
| Q4 24 | $191.4M | $174.2M | ||
| Q3 24 | $227.6M | $147.9M | ||
| Q2 24 | $203.5M | $158.6M | ||
| Q1 24 | $167.8M | $147.6M |
自由现金流REGRVTY
| Q4 25 | — | $161.8M | ||
| Q3 25 | — | $120.0M | ||
| Q2 25 | — | $115.5M | ||
| Q1 25 | — | $112.2M | ||
| Q4 24 | — | $149.8M | ||
| Q3 24 | — | $125.6M | ||
| Q2 24 | — | $136.6M | ||
| Q1 24 | — | $129.7M |
自由现金流率REGRVTY
| Q4 25 | — | 21.0% | ||
| Q3 25 | — | 17.2% | ||
| Q2 25 | — | 16.0% | ||
| Q1 25 | — | 16.9% | ||
| Q4 24 | — | 20.5% | ||
| Q3 24 | — | 18.4% | ||
| Q2 24 | — | 19.7% | ||
| Q1 24 | — | 20.0% |
资本支出强度REGRVTY
| Q4 25 | — | 2.6% | ||
| Q3 25 | — | 2.6% | ||
| Q2 25 | — | 2.6% | ||
| Q1 25 | — | 2.4% | ||
| Q4 24 | — | 3.4% | ||
| Q3 24 | — | 3.3% | ||
| Q2 24 | — | 3.2% | ||
| Q1 24 | — | 2.7% |
现金转化率REGRVTY
| Q4 25 | 1.01× | 1.85× | ||
| Q3 25 | 2.00× | 2.97× | ||
| Q2 25 | 2.30× | 2.49× | ||
| Q1 25 | 1.47× | 3.03× | ||
| Q4 24 | 2.21× | 1.84× | ||
| Q3 24 | 2.24× | 1.57× | ||
| Q2 24 | 1.98× | 2.87× | ||
| Q1 24 | 1.53× | 5.67× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
REG
| Shopping Centers | $418.0M | 103% |
| Propertymanagementservices | $4.1M | 1% |
| Assetmanagementservices | $1.7M | 0% |
RVTY
| Immunodiagnostics | $240.8M | 31% |
| Life Sciences | $191.4M | 25% |
| Reproductive Health | $149.3M | 19% |
| Segment Operating Income | $132.0M | 17% |
| Software | $62.3M | 8% |
